A transcriptional role for MYCN in upregulating the DDR has been given further credence by the recent identification of MYCN binding sites in the promoters of PARP1, PARP2, BRCA1, RMI2, and TOPBP1, albeit in castration resistant prostate cancer [46]. Here, PARP1 is linked to prostate cancer.